More than 700 medical experts, pharmaceutical executives, patient advocates, and others are expected to converge on Washington, D.C., next month…
Larry Luxner
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Larry Luxner
When Shira Zagury joined the Cystic Fibrosis Foundation of Israel as CEO eight years ago, only one cystic fibrosis (CF) patient…
#ECFS2018 – With CF Patients Living Longer, Fertility and Childbirth Concerns Take Center Stage
Cystic fibrosis (CF), once an exclusively pediatric disease, is clearly one no longer. Of the 32,000 or so Europeans registered…
Exercise clearly benefits kids with cystic fibrosis (CF), yet these children often lack the motivation to swim, run, box, play…
#ECFS2018 — Addressing Mental Health Issues Important for Cystic Fibrosis Patients, Experts Say
Anxiety and depression among cystic fibrosis (CF) patients — and their parents — is far more common than most…
SPX-101, designed to help clear mucus from the lungs of people with cystic fibrosis, has the potential to treat all CF…
Some 318,000 health-related software apps are now on the market, with another 200 appearing every day. Yet a British cystic…
Europe’s largest annual gathering of cystic fibrosis (CF) experts ended June 9, capping four days of speeches, workshops, and poster…
The European Cystic Fibrosis Society presented three scientists — one Portuguese, one Mexican, and one German — with the organization’s…
Canada’s healthcare system is excellent for people with common ailments like diabetes or high blood pressure, but it’s “basically failing…